Home » Topics » BioWorld Science

BioWorld Science
RSS

Dermatologic

Jan. 1, 2022

Respiratory

Jan. 1, 2022

Shark variable new antigen receptors identified which neutralize SARS-CoV-2 virus

Dec. 31, 2021

ERRalpha inverse agonist shows significant in vivo activity against breast cancer

Dec. 31, 2021

Piperine-based derivatives identified with activity against breast cancer cells

Dec. 31, 2021

New PD-1/PD-L1 interaction inhibitors identified at Kainos Medicine

Dec. 31, 2021

Kinnate Biopharma discovers FGFR inhibitors

Dec. 31, 2021

CSPC Zhongqi Pharmaceutical Technology patents PTPN11 inhibitors

Dec. 31, 2021

New CDK7 inhibitors presented by ScinnoHub Pharmaceutical

Dec. 31, 2021

Medshine Discovery identifies new NLRP3 inflammasome inhibitors

Dec. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...